These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 5503723)
1. [Electrophysiological effect of Levodopa on the phenomena of spinal inhibition and facilitation in Parkinson's disease]. Cernibori Riv Neurol; 1970; 40(5):303-9. PubMed ID: 5503723 [No Abstract] [Full Text] [Related]
2. [Electrophysiological control of the peripheral effects of L-dopa in Parkinson's disease]. Rovetta P Sist Nerv; 1970; 22(2):191-5. PubMed ID: 5504556 [No Abstract] [Full Text] [Related]
3. [Excitability of the spinal motor neurons in patients with Parkinsonism and athetosis treated with L-dopa]. Messina C Riv Neurol; 1972; 42(3):225-31. PubMed ID: 5071006 [No Abstract] [Full Text] [Related]
4. [Levodopa and Parkinson's disease]. Rinne UK Duodecim; 1971; 87(12):929-32. PubMed ID: 5088231 [No Abstract] [Full Text] [Related]
5. [Clinical results with levodopa in Parkinson's disease]. Crudeli R Sist Nerv; 1970; 22(2):124-5. PubMed ID: 5504551 [No Abstract] [Full Text] [Related]
7. [Treatment of Parkinson's syndrome with levodopa]. Rossi CA Prensa Med Argent; 1970 Oct; 57(31):1516-8. PubMed ID: 5485492 [No Abstract] [Full Text] [Related]
8. [Drug therapy of Parkinson's disease with amantadine and levodopa]. Fieschi C; Nardini M; Casacchia M; Reitano M; Tedone ME; Ferrari P; Robotti E Sist Nerv; 1970; 22(2):126-43. PubMed ID: 5504552 [No Abstract] [Full Text] [Related]
9. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Where do we go from here? Clin Pharmacol Ther; 1971; 12(2):408-16. PubMed ID: 5577487 [No Abstract] [Full Text] [Related]
10. Reappraisal of levodopa therapy for Parkinson's disease. A three-year experience with outpatients in private practice. McFarland HR Mo Med; 1974 Sep; 71(9):535-7. PubMed ID: 4854038 [No Abstract] [Full Text] [Related]
11. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Introduction. McDowell F Clin Pharmacol Ther; 1971; 12(2):317-8. PubMed ID: 5577479 [No Abstract] [Full Text] [Related]
12. [Results of treatment with levodopa and rehabilitative therapy in 10 cases of Parkinson's disease]. Paciaroni E; Raspa EG Sist Nerv; 1970; 22(2):153-61. PubMed ID: 5504554 [No Abstract] [Full Text] [Related]
13. Levodopa and physical therapy in treatment of patients with Parkinson's disease. Stern PH; McDowell F; Miller JM; Robinson M Arch Phys Med Rehabil; 1970 May; 51(5):273-7. PubMed ID: 5420013 [No Abstract] [Full Text] [Related]
14. Pharmacodynamics of 3, 4-dihydroxyphenylalanine (Dopa) in Parkinson's disease. Van Woert MH Conn Med; 1970 Jun; 34(6):401-5. PubMed ID: 5431103 [No Abstract] [Full Text] [Related]
15. [Effect of L-DOPA on the akinesis in Parkinson's syndrome]. Bischoff A Schweiz Med Wochenschr; 1967 Sep; 97(35):1158-9. PubMed ID: 5593650 [No Abstract] [Full Text] [Related]
16. The effect of L-dopa treatment on the speech of patients with Parkinson's disease. Audelman JU; Hoel RL; Lassman FM Neurology; 1970 Apr; 20(4):410-1. PubMed ID: 5535064 [No Abstract] [Full Text] [Related]
18. L-dopa in Parkinson's disease. Cleghorn RA Can Med Assoc J; 1970 Jun; 102(13):1410 passim. PubMed ID: 5422440 [No Abstract] [Full Text] [Related]
19. [Parkinson's disease and its current treatment]. Sigwald J Cah Med; 1971 Jun; 12(10):859-67. PubMed ID: 5112591 [No Abstract] [Full Text] [Related]
20. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature. Lewis I J Med Assoc State Ala; 1971 May; 40(11):709-18. PubMed ID: 5573008 [No Abstract] [Full Text] [Related] [Next] [New Search]